InspireMD, Inc.
NSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13% | 20% | 15% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.5% | 29.1% | 21.6% | 16.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -474% | -337% | -358.2% | -323.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -456.6% | -321% | -357.6% | -331.9% |
| EPS Diluted | -0.76 | -0.82 | -2.35 | -2.03 |
| % Growth | 7.3% | 65.1% | -15.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |